Cambridge Advisors Inc. Novartis Ag Transaction History

Cambridge Advisors Inc.

$441 Million
Q1 2025

A detailed history of Cambridge Advisors Inc. transactions in Novartis Ag stock. As of the latest transaction made, Cambridge Advisors Inc. holds 9,675 shares of NVS stock, worth $1.1 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

9,675

Previous 10,075 3.97%

Holding current value

$1.1 Million

Previous $980,000 10.0%

% of portfolio

0.24%

Previous 0.23%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	SELL	$97.14 - $115.57 $38,856 - $46,228	-400 Reduced 3.97%	9,675 $1.08 Million
Q1 2024 Apr 16, 2024	SELL	$95.27 - $108.47 $66,689 - $75,929	-700 Reduced 6.5%	10,075 $974,000
Q2 2023 Jul 13, 2023	SELL	$92.52 - $104.91 $85,581 - $97,041	-925 Reduced 7.91%	10,775 $1.09 Million
Q1 2023 Apr 13, 2023	SELL	$80.03 - $92.81 $4,001 - $4,640	-50 Reduced 0.43%	11,700 $1.08 Million
Q3 2022 Oct 17, 2022	SELL	$74.61 - $87.26 $113,780 - $133,071	-1,525 Reduced 11.49%	11,750 $893,000
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $80,520 - $93,750	-1,000 Reduced 7.01%	13,275 $1.12 Million
Q1 2022 May 05, 2022	SELL	$80.11 - $90.62 $8,011 - $9,062	-100 Reduced 0.7%	14,275 $1.25 Million
Q4 2021 Jan 14, 2022	SELL	$79.7 - $88.13 $31,880 - $35,252	-400 Reduced 2.71%	14,375 $1.26 Million
Q3 2021 Oct 19, 2021	SELL	$81.78 - $95.14 $4,089 - $4,757	-50 Reduced 0.34%	14,775 $1.21 Million
Q2 2021 Jul 21, 2021	SELL	$85.24 - $94.15 $8,524 - $9,415	-100 Reduced 0.67%	14,825 $1.35 Million
Q2 2019 Jul 26, 2019	SELL	$75.4 - $92.8 $143,260 - $176,320	-1,900 Reduced 11.29%	14,925 $1.36 Million
Q1 2019 Apr 16, 2019	SELL	$75.32 - $86.15 $94,074 - $107,601	-1,249 Reduced 6.91%	16,825 $1.62 Million
Q3 2018 Oct 24, 2018	SELL	$66.94 - $77.43 $15,061 - $17,421	-225 Reduced 1.23%	18,074 $1.56 Million
Q1 2018 Apr 18, 2018	BUY	$70.39 - $84.15 $10,558 - $12,622	150 Added 0.83%	18,299 $1.48 Million
Q4 2017 Jan 26, 2018	SELL	$72.33 - $77.64 $18,154 - $19,487	-251 Reduced 1.36%	18,149 $1.52 Million
Q3 2017 Oct 27, 2017	BUY	$74.14 - $77.27 $1.36 Million - $1.42 Million	18,400	18,400 $1.58 Million

Others Institutions Holding NVS

# of Institutions

1,505

Shares Held

129M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $244B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.

Account

Cambridge Advisors Inc. Novartis Ag Transaction History